Przedstawiamy wybór publikacji naukowych związanych z immunoterapią IOZK. Możesz użyć filtrów, aby dokonać wyboru według typów nowotworów i metod lub wprowadzić wyszukiwane hasła.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-07-01 / Cancer Immunol. Immunother. 2008 Jul;57(7):1039-51https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-07-01 / Cancer Immunol. Immunother. 2008 Jul;57(7):1039-512008-07-01 00:00:002019-02-15 09:19:24Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-07-01 / J. Clin. Oncol. 2008 Jul;26(19):3235-41https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-07-01 / J. Clin. Oncol. 2008 Jul;26(19):3235-412008-07-01 00:00:002019-02-15 09:19:25Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-07-01 / J. Immunother. 2008 Jul-Aug;31(6):555-62https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-07-01 / J. Immunother. 2008 Jul-Aug;31(6):555-622008-07-01 00:00:002019-02-15 09:19:26IFN-producing killer dendritic cells contribute to the inhibitory effect of poly I:C on the progression of murine melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-07-01 / J. Immunother. 2008 Jul-Aug;31(6):591-8https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-07-01 / J. Immunother. 2008 Jul-Aug;31(6):591-82008-07-01 00:00:002019-02-15 09:19:26Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-06-27 / BMC Immunol. 2008 Jun;9:32https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-06-27 / BMC Immunol. 2008 Jun;9:322008-06-27 00:00:002019-02-15 08:50:17Ex vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: critical role of IFN-alpha
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-06-17 / J. Leukoc. Biol. 2008 Oct;84(4):981-7https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-06-17 / J. Leukoc. Biol. 2008 Oct;84(4):981-72008-06-17 00:00:002019-02-15 08:38:03The essential role of the in situ immune reaction in human colorectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-06-16 / Int. J. Urol. 2008 Aug;15(8):694-8https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-06-16 / Int. J. Urol. 2008 Aug;15(8):694-82008-06-16 00:00:002019-02-15 08:48:09Dendritic cell therapy in combination with interferon-alpha for the treatment of metastatic renal cell carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-06-03 / Ann. Surg. Oncol. 2008 Aug;15(8):2310-7https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-06-03 / Ann. Surg. Oncol. 2008 Aug;15(8):2310-72008-06-03 00:00:002021-11-15 17:04:28Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-06-01 / Gan To Kagaku Ryoho 2008 Jun;35(6):926-30https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-06-01 / Gan To Kagaku Ryoho 2008 Jun;35(6):926-302008-06-01 00:00:002019-02-15 08:59:42[Immunotherapy for glioma]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-06-01 / J. Immunother. 2008 Jun;31(5):458-65https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-06-01 / J. Immunother. 2008 Jun;31(5):458-652008-06-01 00:00:002019-02-15 09:19:27Melanoma and lymphoma rejection associated with eosinophil infiltration upon intratumoral injection of dendritic and NK/LAK cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-06-01 / Cancer Biother. Radiopharm. 2008 Jun;23(3):321-31https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-06-01 / Cancer Biother. Radiopharm. 2008 Jun;23(3):321-312008-06-01 00:00:002019-02-15 08:35:00Antitumor effect of lung cancer vaccine with umbilical blood dendritic cells in reconstituted SCID mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-06-01 / Int. J. Oncol. 2008 Jun;32(6):1317-24https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-06-01 / Int. J. Oncol. 2008 Jun;32(6):1317-242008-06-01 00:00:002019-02-15 08:35:00IFN-gamma down-regulates Hsp27 and enhances hyperthermia-induced tumor cell death in vitro and tumor suppression in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-05-29 / Int. J. Radiat. Oncol. Biol. Phys. 2009 Jan;73(1):128-35https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-05-29 / Int. J. Radiat. Oncol. Biol. Phys. 2009 Jan;73(1):128-352008-05-29 00:00:002019-02-15 08:34:59Radiotherapy with 8-MHz radiofrequency-capacitive regional hyperthermia for stage III non-small-cell lung cancer: the radiofrequency-output power correlates with the intraesophageal temperature and clinical outcomes
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-05-17 / Cancer Immunol. Immunother. 2009 Jan;58(1):61-9https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-05-17 / Cancer Immunol. Immunother. 2009 Jan;58(1):61-92008-05-17 00:00:002021-11-15 17:04:52Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial
Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma
Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor
IFN-producing killer dendritic cells contribute to the inhibitory effect of poly I:C on the progression of murine melanoma
Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma
Dendritic cell vaccination with xenogenic polypeptide hormone induces tumor rejection in neuroendocrine cancer
Ex vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: critical role of IFN-alpha
The essential role of the in situ immune reaction in human colorectal cancer
Dendritic cell therapy in combination with interferon-alpha for the treatment of metastatic renal cell carcinoma
Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors
Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy
Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer
[Immunotherapy for glioma]
Melanoma and lymphoma rejection associated with eosinophil infiltration upon intratumoral injection of dendritic and NK/LAK cells
Immunotherapy of pancreatic carcinoma
Antitumor effect of lung cancer vaccine with umbilical blood dendritic cells in reconstituted SCID mice
IFN-gamma down-regulates Hsp27 and enhances hyperthermia-induced tumor cell death in vitro and tumor suppression in vivo
Radiotherapy with 8-MHz radiofrequency-capacitive regional hyperthermia for stage III non-small-cell lung cancer: the radiofrequency-output power correlates with the intraesophageal temperature and clinical outcomes
Functional T-cell responses generated by dendritic cells expressing the early HIV-1 proteins Tat, Rev and Nef
Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial
Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme